Literature DB >> 15708103

Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai.

Zhen-Xin Zhang1, Gustavo C Roman, Zhen Hong, Cheng-Bing Wu, Qiu-Ming Qu, Jue-Bing Huang, Bing Zhou, Zhi-Ping Geng, Ji-Xing Wu, Hong-Bo Wen, Heng Zhao, Gwendolyn E P Zahner.   

Abstract

A cross-sectional prevalence study of Parkinson's disease in China was undertaken in 1997-98. We assessed 29?454 residents aged > or =55 years from 79 rural and 58 urban communities in Beijing, Xian, and Shanghai, who were selected through stratified, multistage, cluster sampling. With a standardised diagnostic protocol, we identified 277 people with the disease. Prevalence of Parkinson's disease for those aged > or =65 years was 1.7% (95% CI 1.5-1.9). We estimate that 1.7 million people in China have the disease (aged > or =55 years). Our findings suggest that prevalence of Parkinson's disease in China is similar to that in developed countries.

Entities:  

Mesh:

Year:  2005        PMID: 15708103     DOI: 10.1016/S0140-6736(05)17909-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  98 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  Parkinson's disease research in a prospective cohort in China.

Authors:  Honglei Chen; Ding Ding; Jian Wang; Qianhua Zhao; Haijiao Meng; Honglan Li; Yu-Tang Gao; Xiao-Ou Shu; Caroline M Tanner; Zhen Hong; Gong Yang
Journal:  Parkinsonism Relat Disord       Date:  2015-08-20       Impact factor: 4.891

Review 3.  Therapeutic strategies for Parkinson's disease: the ancient meets the future--traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells.

Authors:  Xuan Wang; Xi-Bin Liang; Feng-Qiao Li; Hui-Fang Zhou; Xian-Yu Liu; Jian-Jun Wang; Xiao-Min Wang
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

4.  Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Authors:  Jing Zhao; Xun Han; Li Xue; Konghua Zhu; Hongxin Liu; Anmu Xie
Journal:  Neurol Sci       Date:  2015-04-25       Impact factor: 3.307

5.  Dopamine content in the striatum and expression changes of Bad and Bcl-2 in elderly rats with abnormal behavior.

Authors:  Zheng-Quan Yu; Mei-Ying Liu; Qing-Xian Ren; Ye Xiong; Jian-Hui Xu; Cheng-Hua Xiao; Dian-Shuai Gao
Journal:  Neurochem Res       Date:  2011-08-05       Impact factor: 3.996

6.  Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Wei Luo; Xiao-hong Gui; Bo Wang; Wen-ying Zhang; Zhi-yuan Ouyang; Yi Guo; Bao-rong Zhang; Mei-ping Ding
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

7.  Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania.

Authors:  Catherine Dotchin; Ahmed Jusabani; Richard Walker
Journal:  J Neurol       Date:  2011-03-26       Impact factor: 4.849

8.  Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study.

Authors:  Xia Chen; Qian Zhao; Ji Jiang; Jian Liu; Pei Hu
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

Review 9.  Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.

Authors:  Xiaoyun Xu; Jinsha Huang; Jie Li; Ling Liu; Chao Han; Yan Shen; Guoxin Zhang; Haiyang Jiang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Cell Prolif       Date:  2016-01-08       Impact factor: 6.831

Review 10.  Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.

Authors:  Margaret Ragland; Carolyn Hutter; Cyrus Zabetian; Karen Edwards
Journal:  Am J Epidemiol       Date:  2009-10-28       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.